3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Accent Microcell's 3-Year ROIIC % for the quarter that ended in Mar. 2024 was 46.27%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Accent Microcell's 3-Year ROIIC % or its related term are showing as below:
NSE:ACCENTMIC's 3-Year ROIIC % is ranked better than 83.11% of 989
companies
in the Drug Manufacturers industry
Industry Median: 1.5
vs NSE:ACCENTMIC: 46.27
Accent Microcell 3-Year ROIIC % Historical Data
The historical data trend for Accent Microcell's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Accent Microcell 3-Year ROIIC % Chart
Accent Microcell Annual Data
Trend
Mar21
Mar22
Mar23
Mar24
3-Year ROIIC %
-
-
-
46.27
Accent Microcell Semi-Annual Data
Mar21
Mar22
Mar23
Mar24
3-Year ROIIC %
-
-
-
46.27
Competitive Comparison of Accent Microcell's 3-Year ROIIC %
For the Drug Manufacturers - Specialty & Generic subindustry, Accent Microcell's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accent Microcell's 3-Year ROIIC % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Accent Microcell's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Accent Microcell's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Accent Microcell 3-Year ROIIC % Related Terms
Thank you for viewing the detailed overview of Accent Microcell's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.
Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit) which generates maximum revenue, Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:ACCENTMIC has been successfully added to your